Back to Home
    Research & Industry

    Peer-Reviewed, or Just Looks That Way? How to Vet the Research a Stem Cell Clinic Cites

    By RegenMed Review Editorial Team · Medically Reviewed by the RegenMed Review Editorial Team
    November 9, 20265 min read
    Peer-Reviewed, or Just Looks That Way? How to Vet the Research a Stem Cell Clinic Cites

    What this article covers

    What This Article Covers
    Many stem cell clinics point to "published, peer-reviewed research" to back up their treatment claims, and on paper that sounds like exactly the kind of evidence a careful patient should want. But the words "published" and "peer-reviewed" cover an enormous range of quality — from a multi-site randomized controlled trial in a major medical journal to a single case report run in a journal that will print almost anything for a fee.
    What Peer Review Is Supposed to Catch — and What It Doesn't
    Peer review is meant to have independent experts in the field scrutinize a manuscript's methods, statistics, and conclusions before a journal publishes it, catching flaws in study design, undersized or biased samples, and conclusions that overreach the underlying data. It is not a guarantee of truth: peer-reviewed papers are later corrected or retracted, a case report describing one or two patients can clear peer review while saying almost nothing about how a treatment performs across a broader population, and even reputable journals publish early, preliminary findings that later fail to replicate.
    The Rise of Pay-to-Publish "Predatory" Journals
    Alongside legitimate open-access publishing, a large ecosystem of journals exists that charge authors a fee to publish with little or no genuine peer review, while adopting official-sounding names, thin or fabricated editorial boards, and unverifiable "impact factor" claims. Publication-ethics researchers and librarians have documented this problem extensively across medicine generally, and it specifically touches regenerative medicine: researchers who have studied the marketing materials of direct-to-consumer stem cell businesses have found that clinics frequently support their claims with low-quality evidence — small case series, non-peer-reviewed sources, or their own unreplicated in-house findings — rather than the controlled trials that would actually establish whether a treatment works.
    Why Turning Up on PubMed Isn't the Same as Passing Peer Review
    " That reassurance is weaker than it sounds. MEDLINE, the core curated index most people mean when they say "PubMed," only includes journals that a formal technical review committee at the National Library of Medicine has evaluated for scope, editorial quality, and publication standards.
    Five Checks You Can Run Yourself in About Ten Minutes
    Before accepting a cited study as support for a clinic's claims, run it through a short gut-check. First, identify the study type: a randomized controlled trial with a meaningful number of patients proves far more than a single case report or small case series, which can be legitimately published but establishes much less.

    What This Article Covers

    Many stem cell clinics point to "published, peer-reviewed research" to back up their treatment claims, and on paper that sounds like exactly the kind of evidence a careful patient should want. But the words "published" and "peer-reviewed" cover an enormous range of quality — from a multi-site randomized controlled trial in a major medical journal to a single case report run in a journal that will print almost anything for a fee. This article explains what peer review is actually supposed to accomplish, how so-called "predatory" journals create the appearance of legitimate science without the substance, how a study can even turn up in a general PubMed search without ever having passed rigorous editorial review, and a handful of checks you can run yourself in a few minutes before taking a clinic's citations at face value.

    What Peer Review Is Supposed to Catch — and What It Doesn't

    Peer review is meant to have independent experts in the field scrutinize a manuscript's methods, statistics, and conclusions before a journal publishes it, catching flaws in study design, undersized or biased samples, and conclusions that overreach the underlying data. It is not a guarantee of truth: peer-reviewed papers are later corrected or retracted, a case report describing one or two patients can clear peer review while saying almost nothing about how a treatment performs across a broader population, and even reputable journals publish early, preliminary findings that later fail to replicate. The useful question isn't just "was this peer-reviewed," but "what kind of study was it, how many patients were involved, was there a control group, and does the stated conclusion actually match what the data showed."

    The Rise of Pay-to-Publish "Predatory" Journals

    Alongside legitimate open-access publishing, a large ecosystem of journals exists that charge authors a fee to publish with little or no genuine peer review, while adopting official-sounding names, thin or fabricated editorial boards, and unverifiable "impact factor" claims. Publication-ethics researchers and librarians have documented this problem extensively across medicine generally, and it specifically touches regenerative medicine: researchers who have studied the marketing materials of direct-to-consumer stem cell businesses have found that clinics frequently support their claims with low-quality evidence — small case series, non-peer-reviewed sources, or their own unreplicated in-house findings — rather than the controlled trials that would actually establish whether a treatment works.

    Why Turning Up on PubMed Isn't the Same as Passing Peer Review

    Patients are sometimes told, in effect, "look it up — it's on PubMed." That reassurance is weaker than it sounds. MEDLINE, the core curated index most people mean when they say "PubMed," only includes journals that a formal technical review committee at the National Library of Medicine has evaluated for scope, editorial quality, and publication standards. But the PubMed search interface is broader than MEDLINE itself — it also surfaces material such as NIH-funded author manuscripts and other PubMed Central content that did not necessarily go through that same journal-level vetting. Researchers studying this gap have documented that articles from journals with weak or absent peer review can still surface in PubMed results, lending them an air of legitimacy they haven't earned. A citation appearing in a search is a starting point for scrutiny, not the end of it.

    Five Checks You Can Run Yourself in About Ten Minutes

    Before accepting a cited study as support for a clinic's claims, run it through a short gut-check. First, identify the study type: a randomized controlled trial with a meaningful number of patients proves far more than a single case report or small case series, which can be legitimately published but establishes much less. Second, search the journal's name directly and look for a real, named editorial board, a legitimate publisher, and transparent peer-review and fee policies; vague "international" or "global" names, near-instant acceptance timelines, and unsolicited invitations to publish are common predatory-journal signals. Third, check whether the journal itself is MEDLINE-indexed — not merely retrievable through a general PubMed or web search — using the National Library of Medicine's own journal list. Fourth, check whether the study's authors are affiliated with the clinic or have an undisclosed financial stake in the treatment; citing in-house data isn't automatically invalid, but it is a conflict of interest worth knowing about. Fifth, check whether the study has since been corrected, retracted, or contradicted by independent attempts at replication.

    Bottom Line

    A citation is not the same thing as proof, and "peer-reviewed" is not one fixed standard — it spans everything from rigorous, independently replicated trial data to a thinly vetted case report in a journal that exists mainly to collect publication fees. None of this means published research should be dismissed outright; legitimate regenerative medicine findings are published in real, indexed, reputable journals every year, and that body of evidence is exactly what regulatory pathways like FDA-reviewed clinical trials are built on. The task for a prospective patient is simply to ask what kind of study is actually being cited, verify the journal's standing independently rather than taking a clinic's word for it, and weigh a handful of case reports very differently from a well-controlled trial with meaningful follow-up.

    Key Questions Answered

    Does peer review prove that a stem cell treatment works?
    No. Peer review can identify problems but is not a guarantee of truth. Study design, sample size, controls, follow-up and independent replication determine how much a paper can establish.
    Is appearing in PubMed the same as being MEDLINE-indexed?
    No. PubMed includes content beyond the curated MEDLINE journal index, so appearing in a general search does not establish that the journal passed MEDLINE's quality review.
    What should patients check in a clinic's citations?
    Identify the study type, scrutinize the journal's publisher and editorial policies, verify MEDLINE indexing, examine author conflicts and look for corrections, retractions or failed replication.

    Sources

    • Health Products Compliance Guidance, Federal Trade Commission, 2022, https://www.ftc.gov/system/files/ftc_gov/pdf/Health-Products-Compliance-Guidance.pdf
    • Stemming Unproven Stem Cell Therapy Claims, Federal Trade Commission Business Blog, 2018, https://search.ftc.gov/business-guidance/blog/2018/10/stemming-unproven-stem-cell-therapy-claims
    • How Predatory Journals Leak Into PubMed, CMAJ (Canadian Medical Association Journal), 2018, https://www.cmaj.ca/content/190/35/e1042
    • Journal Selection for MEDLINE, National Library of Medicine, https://www.nlm.nih.gov/medline/medline_journal_selection.html
    • The ISSCR Guide to Stem Cell Treatments, International Society for Stem Cell Research, 2024, https://www.isscr.org/resources/patient-guide
    • Weighing Up the Evidence Used by Direct-to-Consumer Stem Cell Businesses, PubMed Central, 2021, https://pmc.ncbi.nlm.nih.gov/articles/PMC8693621/

    Related Articles

    The Review Dispatch

    Our weekly briefing on the regenerative medicine landscape, for researchers, clinicians, and investors.

    regenmedreview

    regenmedreview is an independent reference library covering stem cell therapy and cancer immunotherapy research — compiled for researchers, clinicians, and patients exploring the field.

    The information on this site is for general educational purposes only and does not constitute medical advice. Regenerative medicine treatments discussed here may not be approved or available in all jurisdictions. Always consult a licensed physician before making treatment decisions.

    © 2026 regenmedreview. All rights reserved.Independent. Unaffiliated. Reader-supported.